Leo to market AstraZeneca’s psoriasis treatment outside the EU 15-Aug-2019 By Vassia Barba Leo Pharma acquires exclusive rights to develop and market brodalumab, a treatment for psoriasis, outside of Europe.
AbbVie adds EU approval for potential blockbuster psoriasis drug 02-May-2019 By Ben Hargreaves The European Commission approves Skyrizi for use as a treatment for moderate to severe psoriasis, shortly after it received approval in the US.
AbbVie gets nod for psoriasis drug ahead of Humira patent cliff 24-Apr-2019 By Ben Hargreaves AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humira’s revenue when it loses patent protection.
